Toll Free: 1-888-928-9744
Published: Nov, 2014 | Pages:
25 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Kuros Biosurgery AG - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Kuros Biosurgery AG - Product Pipeline Review - 2014', provides an overview of the Kuros Biosurgery AG's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Kuros Biosurgery AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Kuros Biosurgery AG including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Kuros Biosurgery AG's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Kuros Biosurgery AG's pipeline products Reasons to buy - Evaluate Kuros Biosurgery AG's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Kuros Biosurgery AG in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Kuros Biosurgery AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Kuros Biosurgery AG and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Kuros Biosurgery AG - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Kuros Biosurgery AG and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 3 Kuros Biosurgery AG Snapshot 4 Kuros Biosurgery AG Overview 4 Key Information 4 Key Facts 4 Kuros Biosurgery AG - Research and Development Overview 5 Key Therapeutic Areas 5 Kuros Biosurgery AG - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Kuros Biosurgery AG - Pipeline Products Glance 9 Kuros Biosurgery AG - Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 Phase I Products/Combination Treatment Modalities 10 Kuros Biosurgery AG - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Kuros Biosurgery AG - Drug Profiles 12 KUR-111 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 KUR-113 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 KUR-212 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 KUR-213 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 KUR-115 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Kuros Biosurgery AG - Pipeline Analysis 17 Kuros Biosurgery AG - Pipeline Products by Target 17 Kuros Biosurgery AG - Pipeline Products by Route of Administration 18 Kuros Biosurgery AG - Pipeline Products by Molecule Type 19 Kuros Biosurgery AG - Pipeline Products by Mechanism of Action 20 Kuros Biosurgery AG - Recent Pipeline Updates 21 Kuros Biosurgery AG - Dormant Projects 22 Kuros Biosurgery AG - Locations And Subsidiaries 23 Head Office 23 Appendix 24 Methodology 24 Coverage 24 Secondary Research 24 Primary Research 24 Expert Panel Validation 24 Contact Us 25 Disclaimer 25
List of Tables Kuros Biosurgery AG, Key Information 4 Kuros Biosurgery AG, Key Facts 4 Kuros Biosurgery AG - Pipeline by Indication, 2014 6 Kuros Biosurgery AG - Pipeline by Stage of Development, 2014 7 Kuros Biosurgery AG - Monotherapy Products in Pipeline, 2014 8 Kuros Biosurgery AG - Phase II, 2014 9 Kuros Biosurgery AG - Phase I, 2014 10 Kuros Biosurgery AG - Preclinical, 2014 11 Kuros Biosurgery AG - Pipeline by Target, 2014 17 Kuros Biosurgery AG - Pipeline by Route of Administration, 2014 18 Kuros Biosurgery AG - Pipeline by Molecule Type, 2014 19 Kuros Biosurgery AG - Pipeline Products by Mechanism of Action, 2014 20 Kuros Biosurgery AG - Recent Pipeline Updates, 2014 21 Kuros Biosurgery AG - Dormant Developmental Projects,2014 22
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.